T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Casey's General Stores
CASY
$31.4B
| $852M | 0.08% |
4,316,568
-7,980
| -0.2% | -$1.54M |
|
252
Enovis
ENOV
$1.41B
| $850M | 0.08% |
10,747,217
+5,482
| +0.1% | +$459K |
|
253
Baidu
BIDU
$35.4B
| $845M | 0.08% |
5,679,859
+128,597
| +2% | +$20.1M |
|
254
Boeing
BA
$181B
| $835M | 0.08% |
4,147,946
-11,343
| -0.3% | -$2.4M |
|
255
CME Group
CME
$95.4B
| $834M | 0.08% |
3,651,134
+174,062
| +5% | +$38.3M |
|
256
Chevron
CVX
$387B
| $829M | 0.07% |
7,063,556
-74,296
| -1% | -$8.44M |
|
|
NATI
257
DELISTED
National Instruments Corp
NATI
| $829M | 0.07% |
18,978,320
-971,139
| -5% | -$41.3M |
|
|
PPLI
258
People Inc
PPLI
$3.01B
| $828M | 0.07% |
7,723,365
-92,909
| -1% | -$10.5M |
|
259
QuidelOrtho
QDEL
$1.01B
| $825M | 0.07% |
6,108,899
-280,467
| -4% | -$39M |
|
260
monday.com
MNDY
$3.59B
| $810M | 0.07% |
2,622,976
+1,841,846
| +236% | +$629M |
|
261
Monolithic Power Systems
MPWR
$69.6B
| $807M | 0.07% |
1,635,895
+118,157
| +8% | +$61M |
|
262
Equinix
EQIX
$105B
| $807M | 0.07% |
953,929
+59,068
| +7% | +$47.4M |
|
263
Repligen
RGEN
$9.35B
| $806M | 0.07% |
3,042,655
+737,206
| +32% | +$199M |
|
264
PACCAR
PCAR
$68.2B
| $801M | 0.07% |
13,614,375
+96,879
| +0.7% | +$5.6M |
|
265
Abbott
ABT
$193B
| $799M | 0.07% |
5,674,885
-823,241
| -13% | -$105M |
|
266
Magna International
MGA
$18.7B
| $799M | 0.07% |
9,866,722
-1,670,575
| -14% | -$136M |
|
267
Affirm
AFRM
$25.3B
| $794M | 0.07% |
7,900,335
-3,223,899
| -29% | -$426M |
|
268
Airbnb
ABNB
$109B
| $787M | 0.07% |
4,727,367
-10,652
| -0.2% | -$1.88M |
|
269
MGM Resorts International
MGM
$11.1B
| $776M | 0.07% |
17,280,507
-8,352,490
| -33% | -$375M |
|
270
Cardinal Health
CAH
$53.8B
| $774M | 0.07% |
15,028,767
+605,853
| +4% | +$29.7M |
|
271
Philips
PHG
$26.6B
| $758M | 0.07% |
24,624,097
+1,458,846
| +6% | +$49.6M |
|
272
Dollar Tree
DLTR
$24.8B
| $751M | 0.07% |
5,346,906
+144,594
| +3% | +$17.6M |
|
273
Doximity
DOCS
$4.56B
| $751M | 0.07% |
14,977,874
+9,821,378
| +190% | +$639M |
|
274
Vulcan Materials
VMC
$36.2B
| $749M | 0.07% |
3,607,686
+940,954
| +35% | +$182M |
|
275
Illinois Tool Works
ITW
$82.6B
| $746M | 0.07% |
3,023,072
-153,476
| -5% | -$35.7M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.